Login / Signup
Infliximab Concentrations in Participants with Moderate to Severe COVID-19.
Stephen J Balevic
Dima Dandachi
Danielle Dixon
Richard M W Hoetelmans
Sam Bozzette
Matthew W McCarthy
null null
Published in:
Journal of clinical pharmacology (2023)
Keyphrases
</>
coronavirus disease
sars cov
high intensity
early onset
ulcerative colitis
drug induced